TOR1AIP1 anticorps

N° du produit ABIN7247216

Détail du produit anti-TOR1AIP1 anticorps

Antigène: TOR1AIP1 (Torsin A Interacting Protein 1 (TOR1AIP1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TOR1AIP1 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Antigen affinity purification

Immunogène: Fusion protein of human TOR1AIP1

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:300, ELISA 1:5000-1:10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.2 mg/mL

Buffer: PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur TOR1AIP1

Antigène: TOR1AIP1 (Torsin A Interacting Protein 1 (TOR1AIP1))

Autre désignation: TOR1AIP1 (TOR1AIP1 Produits)

Synonymes: anticorps LAP1, anticorps LAP1B, anticorps Lap1B, anticorps Lap1b, anticorps Lap1c, anticorps torsin 1A interacting protein 1, anticorps torsin A interacting protein 1, anticorps TOR1AIP1, anticorps Tor1aip1

Sujet: This gene encodes a type 2 integral membrane protein that binds A- and B-type lamins. The encoded protein localizes to the inner nuclear membrane and may be involved in maintaining the attachment of the nuclear membrane to the nuclear lamina during cell division. Alternate splicing results in multiple transcript variants. TOR1AIP1 (Torsin 1A Interacting Protein 1) is a Protein Coding gene. Diseases associated with TOR1AIP1 include Muscular Dystrophy, Limb-Girdle, Type 2E. GO annotations related to this gene include cytoskeletal protein binding and ATPase activator activity. An important paralog of this gene is TOR1AIP2.

UniProt: Q5JTV8

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2